N. M. Chowhan
Baptist Health Floyd(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies, Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Lung Cancer Research Studies
Most-Cited Works
- → Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non–Small-Cell Lung Cancer: The Hoosier Oncology Group and U.S. Oncology(2008)493 cited
- → A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study(2007)153 cited
- → Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 Trial(2020)152 cited
- → Intermittent oxaliplatin (oxali) administration and time-to-treatment-failure (TTF) in metastatic colorectal cancer (mCRC): Final results of the phase III CONcePT trial(2008)113 cited
- → Therapy for patients with high grade astrocytoma using intraarterial chemotherapy and radiation therapy(2000)73 cited
- → Improved time to treatment failure with an intermittent oxaliplatin strategy: results of CONcePT(2014)65 cited
- → Phase III trial of cisplatin (P) plus etoposide (E) plus concurrent chest radiation (XRT) with or without consolidation docetaxel (D) in patients (pts) with inoperable stage III non-small cell lung cancer (NSCLC): HOG LUN 01–24/USO-023(2007)60 cited
- → Intracarotid chemotherapy with etoposide and cisplatin for malignant brain tumors(1991)54 cited
- → XL647—A Multitargeted Tyrosine Kinase Inhibitor: Results of a Phase II Study in Subjects with Non-small Cell Lung Cancer Who Have Progressed after Responding to Treatment with Either Gefitinib or Erlotinib(2011)52 cited
- → Management of metastases-induced acute pancreatitis in small cell carcinoma of the lung(1990)35 cited